4.4 Review

Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome

Sounak Gupta et al.

Summary: The incidence of renal neoplasia among patients with polycystic kidney disease (PKD) undergoing nephrectomy was investigated. It was found that 11.3% of PKD patients had renal neoplasia, consisting mainly of low-grade renal cell carcinomas and angiomyolipomas. Screening for PKD1/TSC2 contiguous gene deletion syndrome in patients with TSC-associated renal neoplasia is recommended.

EUROPEAN UROLOGY (2022)

Article Pathology

Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway

Sambit K. Mohanty et al.

Summary: This study found that oncocytic renal tumors with diffuse keratin 7 labeling exhibit frequent alterations in the TSC/MTOR pathway at the molecular level, despite having a morphology more similar to renal oncocytoma. This suggests an expansion of the morphologic spectrum of low-grade oncocytic tumor.

MODERN PATHOLOGY (2022)

Review Pathology

Renal Cell Carcinoma With Fibromyomatous Stroma-The Whole Story

Rajal B. Shah

Summary: Recent studies have confirmed that RCCFMS is a distinct subtype of renal cell carcinoma with unique morphological, immunohistochemical, and molecular characteristics. It can be differentiated from other RCC subtypes and exists in both hereditary and sporadic forms.

ADVANCES IN ANATOMIC PATHOLOGY (2022)

Review Pathology

Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute

Mahmut Akgul et al.

Summary: A study at Indiana University Department of Pathology identified low-grade oncocytic tumour (LOT) as a potentially distinct entity within primary renal epithelial neoplasms, characterized by distinguishable morphology and immunohistochemical profile. Further research with larger cohorts and comprehensive molecular evaluation is needed to definitively recognize LOT as a separate entity and explore active surveillance options for eligible patients.

JOURNAL OF CLINICAL PATHOLOGY (2022)

Article Cell Biology

Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study

Joao Lobo et al.

Summary: In this study, a comparative analysis was performed on six cases of ESC RCC and four cases of TFEB-amplified/translocated RCC. The study found that both types of renal cell carcinoma expressed CK20 and Melan A. Additionally, some cases of ESC RCC and TFEB-amplified RCC were found to have TSC mutations. Therefore, FISH testing for TFEB alterations can aid in the differential diagnosis of these tumors in challenging cases.

HISTOPATHOLOGY (2022)

Article Pathology

Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases

Mihaela Farcas et al.

Summary: EVT is an emerging renal entity with characteristic and readily identifiable morphology, consistent immunohistochemical profile, indolent behavior, and mutations in either TSC1, TSC2, or MTOR genes.

MODERN PATHOLOGY (2022)

Article Pathology

Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1

Aurelien Morini et al.

Summary: The major role of the mTOR pathway in the tumorigenesis of LOT, presence of genetic variations in mTOR pathway related genes, absence of FOXI1 expression as a distinguishing factor, and the potential for targeted therapy in cases of metastasis were highlighted in the study.LOT was considered as a distinct entity with a favorable clinical outcome.

MODERN PATHOLOGY (2022)

Article Pathology

Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney

Payal Kapur et al.

Summary: Low-grade oncocytic tumor (LOT) of the kidney is a distinct entity with characteristic features and mutations in the mTORC1 pathway. Gene expression analysis showed that LOT is separate from related entities, suggesting its unique biological behavior. Additionally, a germline TSC1 mutation was found in one patient with multiple bilateral LOTs, indicating a possible syndromic association.

MODERN PATHOLOGY (2022)

Article Pathology

Xanthomatous Giant Cell Renal Cell Carcinoma Another Morphologic Form of TSC-associated Renal Cell Carcinoma

Pedram Argani et al.

Summary: Several distinct renal epithelial neoplasms driven by TSC/MTOR pathway mutations have been described in the past decade. This study reports two unique TSC2-mutated renal cell carcinomas that do not fit any previously described entity. These neoplasms have distinctive growth patterns and cell morphology, and adding cytokeratin 20 as an epithelial marker helps avoid misdiagnosis.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Pathology

TSC/MTOR-associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum A Targeted Next-generation Sequencing and Gene Expression Profiling Study

Qiu-yuan Xia et al.

Summary: This study evaluated the clinicopathologic and immunohistochemical features of 39 eosinophilic renal tumors with TSC/MTOR mutations. The tumors were reclassified into different subtypes based on morphology and IHC features. RNA sequencing analysis revealed distinct expression profiles for each subtype. TSC-mt RCC-NOS may cluster with recognized TSC/MTOR-associated entities.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Pathology

Renal cell carcinoma with leiomyomatous stroma in tuberous sclerosis complex: a distinct entity

Marjorie Gournay et al.

Summary: Renal cell carcinoma with leiomyomatous stroma (RCCLS) is a newly emerging entity frequently associated with tuberous sclerosis complex (TSC). This study describes the morphological, immunohistochemical, and cytogenetic characteristics of RCCLS in TSC patients, suggesting it could be a distinct entity and a sentinel presentation for the diagnosis of TSC.

VIRCHOWS ARCHIV (2021)

Article Pathology

Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China

Qianru Guo et al.

Summary: Through examining a group of newly defined low-grade oncocytic renal tumors, it is found that these tumors have specific immunohistochemical characteristics, demonstrating unique pathological features including CD117 negative and CK7 positive. These tumors present with a solid growth pattern clinically, showing negative or focal positive results for CD10, vimentin, and other markers.

VIRCHOWS ARCHIV (2021)

Article Pathology

TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study

Melissa Y. Tjota et al.

Summary: This study identified a subset of eosinophilic renal tumors with heterogeneous morphology and immunohistochemical staining patterns, possibly representing a new subtype of RCC characterized by mutations in the TSC/MTOR pathway.

HUMAN PATHOLOGY (2021)

Article Pathology

Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex

L. Angelica Lerma et al.

Summary: This study identified multifocal renal cell tumors with TSC-like morphology, including ESC-RCC, EVT, and LOT. The research provided evidence of the co-existence of ESC-RCC, EVT, and LOT in the same organ.

HUMAN PATHOLOGY (2021)

Article Pathology

Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

Kiril Trpkov et al.

Summary: The Genitourinary Pathology Society conducted a review focusing on recent advances in renal neoplasia, underscoring the importance of both morphology and molecular features for accurate diagnosis. They proposed new criteria for categorizing novel, emerging, and provisional entities in order to clarify the evolving classification of renal neoplasia and reduce the number of unclassifiable cases.

MODERN PATHOLOGY (2021)

Review Pathology

Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss

Payal Kapur et al.

Summary: Recent molecular genetics studies have improved classification of renal tumors, revealing new subtypes like eosinophilic vacuolated tumors (EVT) beyond traditional oncocytomas. EVT show mTORC1 activation and may involve MTOR mutations and chromosome loss as driving factors.

ADVANCES IN ANATOMIC PATHOLOGY (2021)

Review Genetics & Heredity

Renal Cell Carcinoma in Tuberous Sclerosis Complex

Elizabeth P. Henske et al.

Summary: Recent advances in understanding TSC-associated RCC have revealed new insights into the pathology and molecular links with BHD-associated tumors, highlighting similarities in morphological and immunophenotypic features between germline and somatic TSC1/2 mutations.

GENES (2021)

Article Pathology

Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics

Oleksandr Kravtsov et al.

Summary: The study aimed to investigate the long-term clinical follow-up data, clinicopathological and molecular characteristics of low-grade oncocytic tumor of the kidney (LOT). It was found that LOT is a rare but indolent renal neoplasm, representing about 4% of tumors historically diagnosed as oncocytoma, with no identified metastases and a distinct entity in renal neoplasia.

HUMAN PATHOLOGY (2021)

Article Urology & Nephrology

Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course

Renzo G. DiNatale et al.

Summary: TCEB1-mutant RCC is a rare variant with unique characteristics, showing variable behavior from indolent to aggressive. High-stage diseases may have additional oncogenic mutations and whole-genome doubling events, suggesting an association with aggressiveness.

EUROPEAN UROLOGY FOCUS (2021)

Article Medicine, General & Internal

Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients

Sounak Gupta et al.

Summary: The study analyzed 276 renal tumors from 41 TSC patients, with most tumors being benign, but a few showing metastatic behavior. Epithelioid AMLs were enriched for alterations of TP53, RB1, and ATRX. None of the patients died of renal epithelial neoplasms, with most deaths resulting from direct complications of TSC.

MAYO CLINIC PROCEEDINGS (2021)

Review Cell Biology

mTOR at the nexus of nutrition, growth, ageing and disease

Grace Y. Liu et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Urology & Nephrology

Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial

Daniel M. Geynisman et al.

JOURNAL OF UROLOGY (2020)

Article Pathology

Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma

Megan Parilla et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Article Urology & Nephrology

Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma

Rohit Mehra et al.

EUROPEAN UROLOGY (2018)

Letter Cell Biology

Eosinophilic solid and cystic renal cell carcinomas have metastatic potential

Jesse K. McKenney et al.

HISTOPATHOLOGY (2018)

Article Pathology

Renal Cell Carcinoma in Tuberous Sclerosis Complex

Ping Yang et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)

Article Pathology

Tuberous Sclerosis–associated Renal Cell Carcinoma

Juan Guo et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)

Article Urology & Nephrology

Autosomal Dominant Polycystic Kidney Disease: Prevalence of Renal Neoplasias in Surgical Kidney Specimens

Cordula A. Jilg et al.

NEPHRON CLINICAL PRACTICE (2013)

Article Biochemistry & Molecular Biology

TBC1D7 Is a Third Subunit of the TSC1-TSC2 Complex Upstream of mTORC1

Christian C. Dibble et al.

MOLECULAR CELL (2012)

Article Medicine, General & Internal

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

John J. Bissler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Urology & Nephrology

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma

Stephen A. Boorjian et al.

UROLOGY (2007)

Article Urology & Nephrology

Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors

S. K. Rakowski et al.

KIDNEY INTERNATIONAL (2006)

Article Pathology

Angiomyoliploma with epithelial cysts (AMLEC) - A distinct cystic variant of angiomyolipoma

SW Fine et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)

Article Urology & Nephrology

An epidemiological study of renal pathology in tuberous sclerosis complex

FJ O'Callaghan et al.

BJU INTERNATIONAL (2004)

Article Pathology

Concurrent angiomyolipoma and renal cell neoplasia: A study of 36 cases

RE Jimenez et al.

MODERN PATHOLOGY (2001)